Diabetes Research
To learn more about diabetes and ongoing clinical trials in this area, visit our Diabetes Research page.
The main purpose of this study is to assess the safety and tolerability of a single dose of LY3938577 in healthy participants and participants with Type 2 Diabetes Mellitus (T2DM) (Part A) and multiple doses of LY3938577 in participants with T2DM (Part B).
Healthy participants determined by medical evaluation
Have Type 2 Diabetes for at least 1 year prior to screening
Have Stable Body Weight for at least 90 days prior to screening
Have proliferative retinopathy or maculopathy
Have received systemic glucocorticoid therapy
Have a history of heart disease or other heart conditions like heart failure, cerebrovascular stroke
Have been taking weight loss drugs, including over-the-counter medications within 6 months prior to screening
To learn more about diabetes and ongoing clinical trials in this area, visit our Diabetes Research page.
A clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.